Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Jagasia, M., Greinix, H., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J. M., Weisdorf, D. J., Treister, N. S., Cheng, G., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,481 · see citing works

Chronic graft-versus-host syndrome in man

Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R. C., Tsoi, M.-S., Storb, R. F., & Thomas, E. D. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90380-0 · Cited by 2,418 · see citing works

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411 · see citing works

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

Lee, S. J., Klein, J. P., Haagenson, M. D., Baxter‐Lowe, L. A., Confer, D. L., Eapen, M., Fernández-Viña, M., Flomenberg, N., Horowitz, M. M., Hurley, C. K., et al. (2007) · Blood · doi:10.1182/blood-2007-06-097386 · Cited by 1,252 · see citing works

Chronic graft-versus-host disease

Lee, S. J., Vogelsang, G. B., & Flowers, M. E. D. (2003) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2003.50026 · Cited by 956 · see citing works

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203517 · Cited by 919 · see citing works

Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets

Zeiser, R., & Blazar, B. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1703472 · Cited by 750 · see citing works

Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches

Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., & Brink, R. A. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.010 · Cited by 745 · see citing works

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

D’Souza, A., Fretham, C., Lee, S. J., Arora, M., Brunner, J., Chhabra, S., Devine, S. M., Eapen, M., Hamadani, M., Hari, P., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.04.013 · Cited by 714 · see citing works

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

Flomenberg, N. (2004) · Blood · doi:10.1182/blood-2004-03-0803 · Cited by 700 · see citing works

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

Socié, G., Stone, J. V., Wingard, J. R., Weisdorf, D. J., Henslee‐Downey, P. J., Bredeson, C., Cahn, J.-Y. Y., Passweg, J. R., Rowlings, P. A., Schouten, H. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410103 · Cited by 697 · see citing works

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

Flowers, M. E. D., Inamoto, Y., Carpenter, P. A., Lee, S. J., Kiem, H., Petersdorf, E. W., Pereira, S. E., Nash, R. A., Mielcarek, M. B., Fero, M. L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302109 · Cited by 694 · see citing works

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

Wingard, J. R., Majhail, N. S., Brazauskas, R., Wang, Z., Sobocinski, K. A., Jacobsohn, D. A., Sorror, M. L., Horowitz, M. M., Bolwell, B. J., Rizzo, J. D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7212 · Cited by 632 · see citing works

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Nash, R. A., Antin, J. H., Karanes, C., Fay, J. W., Avalos, B. R., Yeager, A. M., Przepiorka, D., Davies, S. M., Petersen, F. B., Bartels, P., et al. (2000) · PubMed · Cited by 589 · see citing works

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Pavletic, S. Z., Martin, P. J., Lee, S. J., Mitchell, S. A., Jacobsohn, D. A., Cowen, E. W., Turner, M. L. C., Akpek, G., Gilman, A. L., McDonald, G. B., et al. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.01.008 · Cited by 564 · see citing works

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

Bhatia, R., Francisco, L., Carter, A. E., Sun, C., Baker, K. S., Gurney, J. G., McGlave, P. B., Nademanee, A. P., O'Donnell, M. R., Ramsay, N. K. C., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082933 · Cited by 540 · see citing works

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

Lee, S. J. (2002) · Blood · doi:10.1182/blood.v100.2.406 · Cited by 540 · see citing works

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Kottaridis, P. D., Milligan, D. W., Chopra, R., Chakraverty, R. K., Chakrabarti, S., Robinson, S. P., Peggs, K. S., Verfuerth, S., Pettengell, R., Marsh, J. C. W., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2419 · Cited by 505 · see citing works

Solid cancers after allogeneic hematopoietic cell transplantation

Rizzo, J. D., Curtis, R. E., Socié, G., Sobocinski, K. A., Gilbert, E. S., Landgren, O., Travis, L. B., Travis, W. D., Flowers, M. E. D., Friedman, D. L., et al. (2008) · Blood · doi:10.1182/blood-2008-05-158782 · Cited by 492 · see citing works

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

Cooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., van den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.023 · Cited by 472 · see citing works

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

Zorn, E., Kim, H. T., Lee, S. J., Floyd, B. H., Litsa, D., Arumugarajah, S., Bellucci, R., Alyea, E. P., Antin, J. H., Soiffer, R. J., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1257 · Cited by 466 · see citing works

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

(2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.020 · Cited by 450 · see citing works

Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Arai, S., Arora, M., Wang, T., Spellman, S. R., He, W., Couriel, D. R., Urbano-Ispizúa, Á., Cutler, C. S., Bacigalupo, A. A., Battiwalla, M., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.10.021 · Cited by 444 · see citing works

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

Lee, S. J., Wolff, D., Kitko, C. L., Koreth, J., Inamoto, Y., Jagasia, M., Pidala, J., Olivieri, A., Martin, P. J., Przepiorka, D., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.02.025 · Cited by 436 · see citing works

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R

Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C. D., Sorichter, S., Gerlach, U. V., Jüttner, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2242 · Cited by 435 · see citing works

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

Weinberg, K. I., Blazar, B. R., Wagner, J. E., Agura, E. D., Hill, B. J., Smogorzewska, M., Koup, R. A., Betts, M. R., Collins, R. H., & Douek, D. C. (2001) · Blood · doi:10.1182/blood.v97.5.1458 · Cited by 422 · see citing works

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

Flowers, M. E. D., Parker, P. M., Johnston, L., Matos, A. V. B., Storer, B. E., Bensinger, W., Storb, R. F., Appelbaum, F. R., Forman, S. J., Blume, K. G., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0011 · Cited by 421 · see citing works

How we treat chronic graft-versus-host disease

Flowers, M. E. D., & Martin, P. J. (2014) · Blood · doi:10.1182/blood-2014-08-551994 · Cited by 374 · see citing works

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Kollman, C., Spellman, S. R., Zhang, M., Hassebroek, A. M., Anasetti, C., Antin, J. H., Champlin, R. E., Confer, D. L., DiPersio, J. F., Fernández-Viña, M., et al. (2015) · Blood · doi:10.1182/blood-2015-08-663823 · Cited by 365 · see citing works

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

Anasetti, C., Beatty, P. G., Storb, R. F., Martin, P. J., Mori, M., Sanders, J. E., Thomas, E. D., & Hansen, J. A. (1990) · Human Immunology · doi:10.1016/0198-8859(90)90071-v · Cited by 337 · see citing works

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

Curtis, R. E. (2005) · Blood · doi:10.1182/blood-2004-09-3411 · Cited by 327 · see citing works

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Dehn, J. G., Spellman, S. R., Hurley, C. K., Shaw, B. E., Barker, J. N., Burns, L. J., Confer, D. L., Eapen, M., Fernández-Viña, M., Hartzman, R. J., et al. (2019) · Blood · doi:10.1182/blood.2019001212 · Cited by 326 · see citing works

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Soiffer, R. J., Kim, H. T., McGuirk, J. P., Horwitz, M. E., Johnston, L., Patnaik, M. M., Rybka, W. B., Artz, A. S., Porter, D. L., Shea, T. C., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.8177 · Cited by 324 · see citing works

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

Sarantopoulos, S., Stevenson, K. E., Kim, H. T., Cutler, C. S., Bhuiya, N. S., Schowalter, M. K., Ho, V. T., Alyea, E. P., Koreth, J., Blazar, B. R., et al. (2009) · Blood · doi:10.1182/blood-2008-09-177840 · Cited by 319 · see citing works

NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

Shulman, H. M., Cardona, D. M., Greenson, J. K., Hingorani, S. R., Horn, T. D., Huber, E., Kreft, A., Longerich, T., Morton, T., Myerson, D., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.12.031 · Cited by 317 · see citing works

Classification systems for chronic graft-versus-host disease

Lee, S. J. (2016) · Blood · doi:10.1182/blood-2016-07-686642 · Cited by 313 · see citing works

Chronic graft-versus-host disease: biological insights from preclinical and clinical studies

MacDonald, K. P. A., Hill, G. R., & Blazar, B. R. (2016) · Blood · doi:10.1182/blood-2016-06-686618 · Cited by 303 · see citing works

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

Schwab, L., Goroncy, L., Palaniyandi, S., Gautam, S., Triantafyllopoulou, A., Mócsai, A., Reichardt, W., Karlsson, F. J., Radhakrishnan, S. V., Hanke, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3517 · Cited by 302 · see citing works

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Socié, G., Schmoor, C., Bethge, W. A., Ottinger, H. D., Stelljes, M., Zander, A. R., Volin, L., Ruutu, T., Heim, D. A., Schwerdtfeger, R., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329821 · Cited by 301 · see citing works

The role of B cells in the pathogenesis of graft-versus-host disease

Shimabukuro‐Vornhagen, A., Hallek, M. J., Storb, R. F., & von Bergwelt‐Baildon, M. S. (2009) · Blood · doi:10.1182/blood-2008-10-161638 · Cited by 272 · see citing works

Prevalence of Hematopoietic Cell Transplant Survivors in the United States

Majhail, N. S., Tao, L., Bredeson, C., Davies, S. M., Dehn, J. G., Gajewski, J., Hahn, T., Jakubowski, A. A., Joffe, S., Lazarus, H. M., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.07.020 · Cited by 259 · see citing works

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants

Randolph, S., Gooley, T. A., Warren, E. H., Appelbaum, F. R., & Riddell, S. R. (2003) · Blood · doi:10.1182/blood-2003-07-2603 · Cited by 259 · see citing works

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

Niederwieser, D. W., Baldomero, H., Bazuaye, N., Bupp, C., Chaudhri, N. A., Corbacioglu, S., Elhaddad, A., Frutos, C., Galeano, S., Hamad, N., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279189 · Cited by 257 · see citing works

High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

Sarantopoulos, S., Stevenson, K. E., Kim, H. T., Bhuiya, N. S., Cutler, C. S., Soiffer, R. J., Antin, J. H., & Ritz, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1290 · Cited by 255 · see citing works

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD

Rieger, K. (2005) · Blood · doi:10.1182/blood-2005-06-2529 · Cited by 243 · see citing works

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

Carpenter, P. A., Kitko, C. L., Elad, S., Flowers, M. E. D., Gea‐Banacloche, J., Halter, J. P., Hoodin, F., Johnston, L., Lawitschka, Á., McDonald, G. B., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.024 · Cited by 236 · see citing works

Quality of life associated with acute and chronic graft-versus-host disease

Lee, S. J., Kim, H. T., Ho, V. T., Cutler, C. S., Alyea, E. P., Soiffer, R. J., & Antin, J. H. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705434 · Cited by 233 · see citing works

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

Chen, X., Vodanovic‐Jankovic, S., Johnson, B. D., Keller, M. R., KOMOROWSKI, R. A., & Drobyski, W. R. (2007) · Blood · doi:10.1182/blood-2007-05-091074 · Cited by 228 · see citing works

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

Majhail, N. S., Brazauskas, R., Rizzo, J. D., Sobecks, R. M., Wang, Z., Horowitz, M. M., Bolwell, B. J., Wingard, J. R., & Socié, G. (2010) · Blood · doi:10.1182/blood-2010-07-294629 · Cited by 223 · see citing works

Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation

Williams, K. M. (2009) · JAMA · doi:10.1001/jama.2009.1018 · Cited by 217 · see citing works

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

Flynn, R. P., Du, J., Veenstra, R. G., Reichenbach, D. K., Panoskaltsis‐Mortari, A., Taylor, P. A., Freeman, G. J., Serody, J. S., Murphy, W. J., Munn, D. H., et al. (2014) · Blood · doi:10.1182/blood-2014-03-562231 · Cited by 216 · see citing works

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

Przepiorka, D., Anderlini, P. N., Saliba, R. M., Cleary, K. R., Mehra, R. C., Khouri, I. F., Huh, Y. O., Giralt, S. A., Braunschweig, I., van Besien, K., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1695 · Cited by 216 · see citing works

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations

Zhang, C., Todorov, I., Zhang, Z., Liu, Y., KANDEEL, F. R., Forman, S. J., Strober, S., & Zeng, D. (2005) · Blood · doi:10.1182/blood-2005-09-3623 · Cited by 215 · see citing works

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

Wingard, J. R., Piantadosi, S., Vogelsang, G. B., Farmer, E. R., Jabs, D. A., Levin, L. S., Beschorner, W. E., Cahill, R. A., Miller, D., & Harrison, D. D. (1989) · Blood · doi:10.1182/blood.v74.4.1428.1428 · Cited by 213 · see citing works

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Khoder, A., Sarvaria, A., Alsuliman, A., Chew, C., Sekine, T., Cooper, N., Mielke, S., de Lavallade, H., Müftüoğlu, M., Curbelo, I. F., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571125 · Cited by 211 · see citing works

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

Carlens, S., Ringdén, O. T. H., Remberger, M., Lönnqvist, B., Hägglund, H., Klaesson, S., Mattsson, J., Svahn, B. ‐., Winiarski, J. H., Ljungman, P. T., et al. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701423 · Cited by 211 · see citing works

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

Clark, F. J., Gregg, R. E., Piper, K., Dunnion, D., Freeman, L., Griffiths, M., Begum, G., Mahendra, P., Craddock, C., Moss, P. A. H., et al. (2003) · Blood · doi:10.1182/blood-2003-06-2073 · Cited by 211 · see citing works

Cutaneous Graft-versus-Host Disease

Aractingi, S., & Chosidow, O. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.5.602 · Cited by 210 · see citing works

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.

Hess, A. D., Horwitz, L. R., Beschorner, W. E., & Santos, G. W. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.4.718 · Cited by 199 · see citing works

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies

Luznik, L., Pasquini, M. C., Logan, B., Soiffer, R. J., Wu, J., Devine, S. M., Geller, N., Giralt, S., Heslop, H. E., Horowitz, M. M., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.02293 · Cited by 185 · see citing works

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Mohty, M., Bay, J., Faucher, C., Choufi, B., Bilger, K., Tournilhac, O., Vey, N., Stoppa, A., Coso, D., Chabannon, C., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3629 · Cited by 184 · see citing works

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

Kitko, C. L., Pidala, J., Schoemans, H. M., Lawitschka, Á., Flowers, M. E. D., Cowen, E. W., Tkaczyk, E. R., Farhadfar, N., Jain, S. K., Steven, P., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.03.033 · Cited by 176 · see citing works

Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease

Sakoda, Y., Hashimoto, D., Asakura, S., Takeuchi, K., Harada, M., Tanimoto, M., & Teshima, T. (2006) · Blood · doi:10.1182/blood-2006-08-042853 · Cited by 160 · see citing works

Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T Cells

Wu, T., Young, J. S., Johnston, H. F., Ni, X., Deng, R., Racine, J. J., Wang, M., Wang, A., Todorov, I., Wang, J., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300657 · Cited by 160 · see citing works

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis

Arora, M., Klein, J. P., Weisdorf, D. J., Hassebroek, A. M., Flowers, M. E. D., Cutler, C. S., Urbano-Ispizúa, Á., Antin, J. H., Bolwell, B. J., Boyiadzis, M. M., et al. (2011) · Blood · doi:10.1182/blood-2010-12-323824 · Cited by 159 · see citing works

Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production

Du, J., Paz, K. G., Flynn, R. P., Vulic, A., Robinson, T. M., Lineburg, K. E., Alexander, K. A., Meng, J., Roy, S., Panoskaltsis‐Mortari, A., et al. (2017) · Blood · doi:10.1182/blood-2017-01-758854 · Cited by 155 · see citing works

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report

Paczesny, S., Hakim, F. T., Pidala, J., Cooke, K. R., Lathrop, J. T., Griffith, L. M., Hansen, J. A., Jagasia, M., Miklos, D. B., Pavletic, S. Z., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.01.003 · Cited by 148 · see citing works

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

DeFilipp, Z. M., Alousi, A. M., Pidala, J. A., Carpenter, P. A., Onstad, L., Arai, S., Arora, M., Cutler, C. S., Flowers, M. E. D., Kitko, C. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004941 · Cited by 148 · see citing works

Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.

Fukushi, N., Arase, H., Wang, B., Ogasawara, K., Gotohda, T., Good, R. A., & Onoé, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6301 · Cited by 133 · see citing works

Impact of Donor and Recipient Sex and Parity on Outcomes of HLA-Identical Sibling Allogeneic Hematopoietic Stem Cell Transplantation

Loren, A. W., Bunin, G. R., Boudreau, C., Champlin, R. E., Cnaan, A., Horowitz, M. M., Loberiza, F. R., & Porter, D. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.03.015 · Cited by 132 · see citing works

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation

Lee, S. J., Logan, B. R., Westervelt, P., Cutler, C. S., Woolfrey, A. E., Khan, S. P., Waller, E. K., Maziarz, R. T., Wu, J., Shaw, B. E., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2520 · Cited by 131 · see citing works

Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.

Holländer, G. A., Widmer, B., & Burakoff, S. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1609 · Cited by 128 · see citing works

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Boyiadzis, M. M., Arora, M., Klein, J. P., Hassebroek, A. M., Hemmer, M., Urbano-Ispizúa, Á., Antin, J. H., Bolwell, B. J., Cahn, J.-Y. Y., Cairo, M. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0586 · Cited by 128 · see citing works

Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

Brüggen, M., Klein, I., Greinix, H., Bauer, W. M., Kuzmina, Z. J., Rabitsch, W., Kalhs, P., Petzelbauer, P., Knobler, R., Stingl, G., et al. (2013) · Blood · doi:10.1182/blood-2013-07-514372 · Cited by 126 · see citing works

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

Inamoto, Y., Storer, B. E., Petersdorf, E. W., Nelson, J. L., Lee, S. J., Carpenter, P. A., Sandmaier, B. M., Hansen, J. A., Martin, P. J., & Flowers, M. E. D. (2013) · Blood · doi:10.1182/blood-2012-10-464198 · Cited by 125 · see citing works

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

Martires, K. J., Baird, K., Steinberg, S. M., Grkovic, L. D., Joe, G. O., Williams, K. M., Mitchell, S. A., Datiles, M. B., Hakim, F. T., Pavletic, S. Z., et al. (2011) · Blood · doi:10.1182/blood-2011-04-350249 · Cited by 124 · see citing works

Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation—Results from a Single-Center Observational Study

Grube, M., Holler, E., Weber, D., Holler, B., Herr, W., & Wolff, D. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.06.020 · Cited by 123 · see citing works

Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.

Schultz, K. R., Paquet, J., Bader, S. A., & HayGlass, K. T. (1995) · PubMed · Cited by 122 · see citing works

Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation: Report from the Bone Marrow Transplantation Survivor Study

Sun, C., Kersey, J. H., Francisco, L., Armenian, S. H., Baker, K. S., Weisdorf, D. J., Forman, S. J., & Bhatia, R. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.04.002 · Cited by 121 · see citing works

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium

Jacobsohn, D. A., Kurland, B. F., Pidala, J., Inamoto, Y., Chai, X., Palmer, J. M., Arai, S., Arora, M., Jagasia, M., Cutler, C. S., et al. (2012) · Blood · doi:10.1182/blood-2012-04-424135 · Cited by 121 · see citing works

Emergent autoimmunity in graft-versus-host disease

Tivol, E. A., KOMOROWSKI, R. A., & Drobyski, W. R. (2005) · Blood · doi:10.1182/blood-2004-12-4980 · Cited by 121 · see citing works

Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management

Zantomio, D., Grigg, A., MacGregor, L., Panek‐Hudson, Y., Szer, J., & Ayton, R. A. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705487 · Cited by 117 · see citing works

Resilience, health, and quality of life among long‐term survivors of hematopoietic cell transplantation

Rosenberg, A. R., Syrjala, K. L., Martin, P. J., Flowers, M. E., Carpenter, P. A., Salit, R. B., Baker, K. S., & Lee, S. J. (2015) · Cancer · doi:10.1002/cncr.29651 · Cited by 109 · see citing works

Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner

McDonald-Hyman, C. S., Flynn, R. P., Panoskaltsis‐Mortari, A., Peterson, N., MacDonald, K. P. A., Hill, G. R., Luznik, L., Serody, J. S., Murphy, W. J., Maillard, I. P., et al. (2016) · Blood · doi:10.1182/blood-2016-05-715896 · Cited by 109 · see citing works

Incidence and Outcome of Chronic Graft-versus-Host Disease Using National Institutes of Health Consensus Criteria

Jagasia, M., Giglia, J. L., Chinratanalab, W., Dixon, S., Chen, H., Frangoul, H., Engelhardt, B. G., Goodman, S. A., Greer, J. P., Kassim, A. A., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.07.001 · Cited by 107 · see citing works

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report

Armenian, S. H., Chemaitilly, W., Chen, M. Y., Chow, E. J., Duncan, C., Jones, L. W., Pulsipher, M. A., Remaley, A. T., Rovó, A., Salooja, N., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.019 · Cited by 107 · see citing works

Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response

Liu, Y., Wu, Y. P., Ramarathinam, L., Guo, Y., Huszar, D., Trounstine, M. L., & Zhao, M. (1995) · International Immunology · doi:10.1093/intimm/7.8.1353 · Cited by 106 · see citing works

Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.

Spinelli, S., Chiodi, S., Costantini, S., Lint, M. T. V., Raiola, A. M., Ravera, G., & Bacigalupo, A. P. (2003) · PubMed · Cited by 103 · see citing works

Patient-reported outcomes and health status associated with chronic graft- versus -host disease

Lee, S. J., Onstad, L., Chow, E. J., Shaw, B. E., Jim, H., Syrjala, K. L., Baker, K. S., Buckley, S. A., & Flowers, M. E. D. (2018) · Haematologica · doi:10.3324/haematol.2018.192930 · Cited by 100 · see citing works

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice

Jin, H., Ni, X., Deng, R., Song, Q., Young, J. S., Cassady, K. M., Zhang, M., Forman, S. J., Martin, P. J., Liu, Q., et al. (2016) · Blood · doi:10.1182/blood-2015-09-668145 · Cited by 99 · see citing works

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Olivieri, A., Cimminiello, M., Corradini, P., Mordini, N., Fedele, R., Selleri, C., Onida, F., Patriarca, F. F., Pavone, E., Svegliati, S., et al. (2013) · Blood · doi:10.1182/blood-2013-05-494278 · Cited by 98 · see citing works

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

Schmid, C., Labopin, M., Schaap, N. P., Veelken, H., Brecht, A., Stadler, M., Finke, J., Baron, F., Collin, M. P., Bug, G., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01515-3 · Cited by 98 · see citing works

Impaired thymic negative selection causes autoimmune graft-versus-host disease

Teshima, T., Reddy, P. R., Liu, C., Williams, D., Cooke, K. R., & Ferrara, J. L. M. (2003) · Blood · doi:10.1182/blood-2003-01-0266 · Cited by 95 · see citing works

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

Pidala, J., Vogelsang, G. B., Martin, P., Chai, X., Storer, B. E., Pavletic, S. Z., Weisdorf, D. J., Jagasia, M., Cutler, C. S., Palmer, J. M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.055186 · Cited by 92 · see citing works

Patterns of gonadal dysfunction following bone marrow transplantation

Mertens, A., Ramsay, N., Kouris, S., & Neglia, J. P. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701342 · Cited by 92 · see citing works

Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Remberger, M., Kumlien, G., ASCHAN, J., Barkholt, L., Hentschke, P., Ljungman, P. T., Mattsson, J., Svennilson, J., & Ringdén, O. T. H. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.abbmt080674 · Cited by 89 · see citing works

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition

Forcade, É., Paz, K. G., Flynn, R. P., Griesenauer, B., Amet, T., Li, W., Liu, L., Bakoyannis, G., Jiang, D., Chu, H. W., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92111 · Cited by 89 · see citing works

Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: Expanding the sclerodermoid spectrum

Schaffer, J. V., McNiff, J. M., Seropian, S., COOPER, D. L., & Bolognia, J. L. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.06.015 · Cited by 88 · see citing works

Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy

Pérez‐Simón, J. A., Encinas, C., Silva, F., Arcos, M. J., Díez‐Campelo, M., Sanchez-Guijo, F. M., Colado, E., Martín, J., Vázquez, L., del Cañizo, C., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.07.015 · Cited by 88 · see citing works

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

Arai, S., Pidala, J., Pusic, I., Chai, X., Jaglowski, S. M., Khera, N., Palmer, J. M., Chen, G. L., Jagasia, M., Mayer, S. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1443 · Cited by 87 · see citing works

Prediction of cardiovascular disease among hematopoietic cell transplantation survivors

Armenian, S. H., Yang, D., Teh, J. B., Atencio, L., Gonzales, A., Wong, F. L., Leisenring, W. M., Forman, S. J., Nakamura, R., & Chow, E. J. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018019117 · Cited by 86 · see citing works

Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells

Du, J., Paz, K. G., Thangavelu, G., Schneidawind, D., Baker, J. B., Flynn, R. P., Duramad, O., Feser, C. J., Panoskaltsis‐Mortari, A., Negrin, R. S., et al. (2017) · Blood · doi:10.1182/blood-2016-11-752444 · Cited by 84 · see citing works

Oral Disease Profiles in Chronic Graft versus Host Disease

Bassim, C. W., Fassil, H., Mays, J. W., Edwards, D., Baird, K., Steinberg, S. M., Cowen, E. W., Naik, H. B., Datiles, M. B., Stratton, P., et al. (2015) · Journal of Dental Research · doi:10.1177/0022034515570942 · Cited by 82 · see citing works

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management

Griffith, M. L., Savani, B. N., & Boord, J. B. (2010) · Blood · doi:10.1182/blood-2010-03-276576 · Cited by 81 · see citing works

Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis

Bachier, C. R., Aggarwal, S. K., Hennegan, K., Milgroom, A., Francis, K. M., Dehipawala, S., & Rotta, M. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.12.027 · Cited by 81 · see citing works

Three US Food and Drug Administration–approved therapies for chronic GVHD

Zeiser, R., & Lee, S. J. (2022) · Blood · doi:10.1182/blood.2021014448 · Cited by 81 · see citing works

Programmed Death-1 Pathway in Host Tissues Ameliorates Th17/Th1-Mediated Experimental Chronic Graft-versus-Host Disease

Fujiwara, H., Maeda, Y., Kobayashi, K., Nishimori, H., Matsuoka, K., Fujii, N., Kondo, E., Tanaka, T., Chen, L., Azuma, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400954 · Cited by 80 · see citing works

Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD

Dertschnig, S., Hauri-Hohl, M. M., Vollmer, M., Holländer, G. A., & Krenger, W. (2015) · Blood · doi:10.1182/blood-2014-08-597245 · Cited by 75 · see citing works

Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD

Tirri, B. F., Häusermann, P., Bertz, H., Greinix, H., Lawitschka, Á., Schwarze, C. P., Wolff, D., Halter, J. P., Dörfler, D., & Moffat, R. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.242 · Cited by 68 · see citing works

Eczematoid Graft-vs-Host Disease

Creamer, D., Martyn-Simmons, C. L., Osborne, G., Kenyon, M., Salisbury, J. R., Devereux, S., Pagliuca, A., Ho, A. Y. L., Mufti, G. J., & du Vivier, A. W. P. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.9.1157 · Cited by 66 · see citing works

Chronic graft‐versus‐host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program

Ozawa, S., Nakaseko, C., Nishimura, M., Maruta, A., Cho, R., Ohwada, C., Sakamaki, H., Sao, H., Mori, S., Okamoto, S., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06543.x · Cited by 66 · see citing works

Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease

Palmer, J. M., Chai, X., Pidala, J., Inamoto, Y., Martin, P. J., Storer, B. E., Pusic, I., Flowers, M. E. D., Arora, M., Pavletic, S. Z., et al. (2015) · Blood · doi:10.1182/blood-2015-08-662874 · Cited by 65 · see citing works

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report

Morton, L. M., Saber, W., Baker, K. S., Barrett, A. J., Bhatia, S., Engels, E. A., Gadalla, S. M., Kleiner, D. E., Pavletic, S. Z., & Burns, L. J. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.005 · Cited by 65 · see citing works

Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-versus-Host Disease

Baird, K., Comis, L. E., Joe, G. O., Steinberg, S. M., Hakim, F. T., Rose, J. J., Mitchell, S. A., Pavletic, S. Z., Figg, W. D., Yao, L., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.006 · Cited by 64 · see citing works

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation

Norkin, M., Shaw, B. E., Brazauskas, R., Tecca, H. R., Leather, H. L., Gea‐Banacloche, J., Kamble, R. T., DeFilipp, Z. M., Jacobsohn, D. A., Ringdén, O. T. H., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.031 · Cited by 59 · see citing works

Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients

Tichelli, A., Beohou, E., Labopin, M., Socié, G., Rovó, A., Badoglio, M., van Biezen, A., Bader, P., Duarte, R. F., Basak, G. W., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4934 · Cited by 57 · see citing works

Machine learning reveals chronic graft- versus -host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies

Gandelman, J. S., Byrne, M. T., Mistry, A. M., Polikowsky, H. G., Diggins, K. E., Chen, H., Lee, S. J., Arora, M., Cutler, C. S., Flowers, M. E. D., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.193441 · Cited by 55 · see citing works

Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

Kline, J. P., Subbiah, S. S., Lazarus, H. M., & van Besien, K. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705931 · Cited by 55 · see citing works

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report

Williams, K. M., Inamoto, Y., Im, A., Hamilton, B. K., Koreth, J., Arora, M., Pusic, I., Mays, J. W., Carpenter, P. A., Luznik, L., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.02.035 · Cited by 53 · see citing works

Genital Chronic GVHD in Men after Hematopoietic Stem Cell Transplantation: A Single-Center Cross-Sectional Analysis of 155 Patients

Mueller, S. M., Haeusermann, P., Rovó, A., Halter, J. P., Passweg, J. R., Itin, P. H., & Tichelli, A. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.07.010 · Cited by 50 · see citing works

Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft‐versus‐host disease

Hillen, U., Häusermann, P., Massi, D., Janin, A., Wolff, D., Lawitschka, Á., Greinix, H., Meyer, R.-G., & Ziemer, M. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12737 · Cited by 48 · see citing works

Unilateral linear lichenoid eruption after bone marrow transplantation: An unmasking of tolerance to an abnormal keratinocyte clone?

Beers, B. B., Kalish, R. S., Kaye, V. N., & Dahl, M. V. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70126-e · Cited by 47 · see citing works

Clinical significance of autoantibodies in a large cohort of patients with chronic graft‐versus‐host disease defined by NIH criteria

Kuzmina, Z. J., Gounden, V., Curtis, L. M., Avila, D. N., Tiffani Taylor, R. N. P., Baruffaldi, J. L., Cowen, E. W., Naik, H. B., Hasni, S., Mays, J. W., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23885 · Cited by 46 · see citing works

Localization of Sclerotic-type Chronic Graft-vs-Host Disease to Sites of Skin Injury

Martires, K. J. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.226 · Cited by 45 · see citing works

Genital Chronic Graft-versus-Host Disease in Females: A Cross-Sectional Study

Knutsson, E. S., Björk, Y., Broman, A., Helström, L., Jakobsen, A.-M. L., Nilsson, O., Sundfeldt, K., & Brune, M. L. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.016 · Cited by 44 · see citing works

Anti–IL-12/23 p40 Antibody Attenuates Experimental Chronic Graft-versus-Host Disease via Suppression of IFN-γ/IL-17–Producing Cells

Okamoto, S., Fujiwara, H., Nishimori, H., Matsuoka, K., Fujii, N., Kondo, E., Tanaka, T., Yoshimura, A., Tanimoto, M., & Maeda, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400973 · Cited by 43 · see citing works

Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia: Refined HLA Matching Reveals More Graft-versus-Host Disease but not Less Relapse

Weisdorf, D. J., Nelson, G. O., Lee, S. J., Haagenson, M. D., Spellman, S. R., Antin, J. H., Bolwell, B. J., Cahn, J.-Y. Y., Cervantes, F., Copelan, E. A., et al. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.06.016 · Cited by 41 · see citing works

Atypical manifestations of graft-versus-host disease

Cornejo, C. M., Kim, E. J., Rosenbach, M. A., & Micheletti, R. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.12.022 · Cited by 38 · see citing works

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML

Malladi, R. K., Peniket, A., Littlewood, T. J., Towlson, K. E., Pearce, R., Yin, J. A. L., Cavenagh, J. D., Craddock, C., Orchard, K. H., Olavarría, E., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.375 · Cited by 35 · see citing works

Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease

Zuo, R. C., Naik, H. B., Steinberg, S. M., Baird, K., Mitchell, S. A., Kuzmina, Z. J., Pavletic, S. Z., & Cowen, E. W. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.1550 · Cited by 33 · see citing works

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD

Curtis, L. M., Grkovic, L. D., Mitchell, S. A., Steinberg, S. M., Cowen, E. W., Datiles, M. B., Mays, J. W., Bassim, C. W., Joe, G. O., Comis, L. E., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.188 · Cited by 33 · see citing works

Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis

Bhatt, V. R., Wang, T., Chen, K., Kitko, C. L., MacMillan, M. L., Pidala, J. A., Malki, M. M. A., Badawy, S. M., Beitinjaneh, A., Ganguly, S., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.10.002 · Cited by 33 · see citing works

Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease

Zerr, P., Distler, A., Palumbo‐Zerr, K., Tomčík, M., Vollath, S., Dees, C., Egberts, F., Tinazzi, I., Galdo, F. D., Distler, O., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.017 · Cited by 32 · see citing works

Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease

Bidgoli, A., DePriest, B. P., Saatloo, M. V., Jiang, H., Fu, D., & Paczesny, S. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.07.008 · Cited by 32 · see citing works

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival

Alousi, A. M., Wang, T., Hemmer, M., Spellman, S. R., Arora, M., Couriel, D. R., Pidala, J., Anderlini, P. N., Boyiadzis, M. M., Bredeson, C., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.004 · Cited by 29 · see citing works

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

Arora, M., Pidala, J., Cutler, C. S., Chai, X., Kurland, B. F., Jacobsohn, D. A., Pavletić, S. Ž., Palmer, J. M., Vogelsang, G. B., Jagasia, M., et al. (2012) · Leukemia · doi:10.1038/leu.2012.292 · Cited by 28 · see citing works

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis

Pidala, J., Sigdel, T. K., Wang, A., Hsieh, S., Inamoto, Y., Martin, P. J., Flowers, M. E. D., Hansen, J. A., Lee, S. J., & Sarwal, M. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.58 · Cited by 28 · see citing works

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

Baron, F., Galimard, J., Labopin, M., Yakoub‐Agha, I., Niittyvuopio, R., Kröger, N. M., Griškevičius, L., Wu, D., Forcade, É., Richard, C., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.227603 · Cited by 26 · see citing works

Chronic graft-versus-host disease with skin signs suggestive of dermatomyositis.

Arin, M. J., Scheid, C., Hübel, K., Krieg, T. M., Groth, W., & Herrmann, G. F. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01934.x · Cited by 25 · see citing works

The Isomorphic Response in Morphealike Chronic Graft-vs-Host Disease

Patel, A. R., Pavletic, S. Z., Turner, M. L. C., & Cowen, E. W. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.9.1229 · Cited by 23 · see citing works

High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease

Čeović, R., Desnica, L., Pulanić, D., Seiwerth, R. S., Ilić, I., Grce, M., Mravak‐Stipetić, M., Pulanić, T. K., Bilić, E., Bilić, E., et al. (2016) · Croatian Medical Journal · doi:10.3325/cmj.2016.57.229 · Cited by 23 · see citing works

Factors associated with social functioning among long‐term cancer survivors treated with hematopoietic stem cell transplantation as adolescents or young adults

Walsh, C., Yi, J. C., Rosenberg, A. R., Crouch, M.-L., Leisenring, W. M., & Syrjala, K. L. (2020) · Psycho-Oncology · doi:10.1002/pon.5460 · Cited by 22 · see citing works

Graft-versus-host disease-associated angiomatosis: A clinicopathologically distinct entity

Kaffenberger, B. H., Zuo, R. C., Gru, A. A., Plotner, A. N., Sweeney, S. A., Devine, S. M., Hymes, S. R., & Cowen, E. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.05.034 · Cited by 21 · see citing works

Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease

Schain, F., Batyrbekova, N., Liwing, J., Baculea, S., Webb, T., Remberger, M., & Mattsson, J. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01249-x · Cited by 21 · see citing works

Chronic Cutaneous Graft-Versus-Host Disease Simulating Hypertrophic Lupus Erythematosus—A Case Report of a New Morphologic Variant of Graft-Versus-Host Disease

Hu, S. W., Myskowski, P. L., Papadopoulos, E. B., & BUSAM, K. J. (2012) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31823395f0 · Cited by 18 · see citing works

What else do I need to worry about when treating graft-versus-host disease?

El-Jawahri, A. R. (2021) · Hematology · doi:10.1182/hematology.2021000302 · Cited by 16 · see citing works

Specificity of effector mechanisms in syngeneic graft-vs-host disease: Recognition of the MHC class II invariant chain peptide (CLIP)

Hess, A. D., Thoburn, C. J., Bright, E. C., & Horwitz, L. R. (1997) · Transplantation Proceedings · doi:10.1016/s0041-1345(96)00441-1 · Cited by 15 · see citing works

Characteristics of graft‐versus‐host disease occurring after alemtuzumab‐containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival

Finazzi, M. C., Boschini, C., Craddock, C., Rambaldi, A., Ward, J., & Malladi, R. K. (2019) · British Journal of Haematology · doi:10.1111/bjh.16200 · Cited by 14 · see citing works

Rippled skin, fasciitis, and joint contractures

Patel, A. R., Avila, D. N., Malech, H. L., Pavletic, S. Z., Yao, L., & Cowen, E. W. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.08.023 · Cited by 13 · see citing works

A Case of Chronic Cutaneous Graft Versus Host Disease with the Clinical Features of Exfoliative Dermatitis

Ahn, H. S., Park, H. J., Lee, J. Y., & Cho, B. K. (2009) · Annals of Dermatology · doi:10.5021/ad.2009.21.3.319 · Cited by 11 · see citing works

Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease

Smith, Z. I., Rosenstein, R. K., Banerjee, S. K., Pichard, D. C., Pavletic, S. Z., & Cowen, E. W. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.4857 · Cited by 11 · see citing works

Effect of Vitamin D on Graft-versus-Host Disease

Rodríguez‐Gil, A., Carrillo‐Cruz, E., Marrero-Cepeda, C., Rodriguez, G., & Pérez‐Simón, J. A. (2022) · Biomedicines · doi:10.3390/biomedicines10050987 · Cited by 11 · see citing works

Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults

Naftulin, J. S., Penzi, L. R., Manatis-Lornell, A. J., Yasuda, M. R., Porter, M. L., Saavedra, A. P., & Senna, M. M. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0309-z · Cited by 10 · see citing works

Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease

Schaar, D. A., Pirsl, F., Holtzman, N. G., Steinberg, S. M., Nashed, J., Ruben, C. L., Cowen, E. W., Mays, J. W., Mitchell, S. A., Ostojić, A., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.08.001 · Cited by 10 · see citing works

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation

Sanlı, H. E., Akay, B. N., Soydan, E., Koçyiğit, P., Arat, M., & İlhan, O. (2010) · Turkish Journal of Hematology · doi:10.5152/tjh.2010.06 · Cited by 7 · see citing works

Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib

Borg, M. A., Shalabi, R. A., Childs, R. W., & Wells, B. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.2927 · Cited by 7 · see citing works

Épidermolyse bulleuse acquise et réaction du greffon contre l’hôte

Brassat, S., Fleury, J., CAMUS, M.-C., du Sorbier, C. M., & Guillet, G. (2014) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2014.01.014 · Cited by 3 · see citing works

Mesenchymal stromal/stem cell (MSC)-Derived exosomes in clinical trials

Lotfy, A., AboQuella, N. M., & Wang, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03287-7 · Cited by 482 · see citing works

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · see citing works

An open‐label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid‐dependent/steroid‐resistant chronic GVHD

Inamoto, Y., Kato, K., Kawakita, T., Onishi, Y., Matsuoka, K., Shiratori, S., Ikegame, K., Hiramoto, N., Toyosaki, M., Katayama, Y., et al. (2024) · American Journal of Hematology · doi:10.1002/ajh.27424 · Cited by 30 · see citing works

Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies

Nguyen, J. T., Jessri, M., Costa-da-Silva, A. C., Sharma, R., Mays, J. W., & Treister, N. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910411 · Cited by 19 · see citing works

Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease

Alvarado, S. M., Cohen, O. G., Lattanzio, K., Haun, P., Gelfand, J. M., Loren, A. W., Chung, J., & Baumrin, E. (2024) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000002841 · Cited by 10 · see citing works

Phototherapy for the treatment of cutaneous graft‐versus‐host disease: A systematic review

Fachler, T., Kobal, I., Sheffer‐Levi, S., Cohen, A., Hassidim, A., Molho‐Pessach, V., & Shreberk‐Hassidim, R. (2024) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12997 · Cited by 9 · see citing works

The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial

Mohseni, R., Sharif, P. M., Khosravi, A., Taheri, A. R., Behfar, M., Zarrabi, M., Jafari, L., Jafari, F., Nikfetrat, Z., Naji, P., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.04.013 · Cited by 9 · see citing works

Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease

Rosenstein, R. K., Rose, J. J., Brooks, S. R., Tsai, W. L., Gadina, M., Pavletic, S. Z., Nagao, K., & Cowen, E. W. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100246 · Cited by 8 · see citing works

Belumosudil in pediatric patients with chronic graft-versus-host disease after failed multi-line therapy: a case series

Chen, W., Wang, Z., Liu, Z., Fu, B., Xing, T., You, J., & Hu, J. (2024) · Annals of Hematology · doi:10.1007/s00277-024-06128-6 · Cited by 7 · see citing works

Efficacy and safety of axatilimab in chronic graft-versus-host disease: A systematic review and meta-analysis

Bahbah, E. I., Attia, M. M., & Ali, M. M. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104855 · Cited by 6 · see citing works

Symptom clusters and sentinel symptoms during post-transplant recovery in recipients of allogeneic hematopoietic stem cell transplantation: A cross-sectional study

Xu, P., Ding, S., Zheng, L., Cheng, Y., Ye, Y., Lin, L., Li, Z., Tao, Y., & Wang, H. (2025) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2025.100782 · Cited by 5 · see citing works

The role of MSC-derived exosomes in immune modulation and regenerative medicine

Pandey, S. N., Afzal, M., Goyal, K., Rekha, M. M., Nayak, P. P., Maqbool, M., Khan, Y., Maji, C., Gupta, G., Alzarea, S. I., et al. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2620707 · Cited by 5 · see citing works

Early intervention with oral mucosal barrier Protective agents in chronic oral graft-versus-host disease: a retrospective cohort study

Cao, J., Ye, L., Li, X., Song, Q., & Chai, Y. (2024) · BMC Oral Health · doi:10.1186/s12903-024-04724-6 · Cited by 5 · see citing works

Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation

Siemaszko, J., Łacina, P., Szymczak, D., Szeremet, A., Majcherek, M., Czyż, A., Sobczyk‐Kruszelnicka, M., Fidyk, W., Solarska, I., Nasiłowska‐Adamska, B., et al. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.111147 · Cited by 5 · see citing works

The rise of exosome-mediated mechanisms in MSC therapy

Liu, W., Chen, S., Wang, Y., & Gong, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06747-1 · Cited by 5 · see citing works

Chronic graft-versus-host disease: Current situation and unmet needs — A European position statement

Malard, F., Perić, Z., Ruggeri, A., Gedde-Dahl, T., Bazarbachi, A. A., Ciceri, F., Mehra, V., Blaise, D., Kinsella, F. A. M., Schoemans, H. M., et al. (2026) · Bone Marrow Transplantation · doi:10.1038/s41409-026-02817-0 · Cited by 4 · see citing works

Targeting hypoxia-inducible factor 1α in chronic graft-versus-host disease to enhance graft-versus-leukemia responses: implications for nanotherapeutics

Wang, Y., & Zhou, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1605669 · Cited by 3 · see citing works

Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease

Swallow, M. A., Chang, J., Carlson, K. R., Odell, I. D., & Girardi, M. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-024-03770-y · Cited by 3 · see citing works

Risk factors for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation: a systematic review and meta-analysis

Pu, G., Nong, G., Wei, Q., He, Y., Jia, W., Lu, Z., Qiu, G., Xie, J., & Chen, X. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03925-1 · Cited by 2 · see citing works

Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!

Rapparini, L., Touhouche, A. T., Fattore, D., Freites‐Martínez, A., Hirtz, P., Apalla, Z., Vigarios, É., Maret, D., Starace, M. V. R., & Sibaud, V. (2026) · American Journal of Clinical Dermatology · doi:10.1007/s40257-026-01027-0 · Cited by 2 · see citing works

Ocular manifestations and quality of life in patients after hematopoietic stem cell transplantation

Fan, S.-X., Zeng, P. C., Huang, K., Hu, Y., Wang, J., Li, Y., & Xiao, J. (2023) · International Journal of Ophthalmology · doi:10.18240/ijo.2023.07.20 · Cited by 2 · see citing works

Skin Hypopigmentation in Hematology Disorders

Mazzetto, R., Miceli, P., Sernicola, A., Tartaglia, J., & Alaibac, M. (2024) · Hematology Reports · doi:10.3390/hematolrep16020036 · Cited by 1 · see citing works

Pharmacogenetics of graft-versus-host disease: a path to personalized medicine

Łacina, P., Siemaszko, J., & Bogunia‐Kubik, K. (2025) · Pharmacogenomics · doi:10.1080/14622416.2025.2541404 · Cited by 1 · see citing works

Microbiota–fibroblast crosstalk represents the missing link in skin barrier dysfunction and fibrosis

Lin, Z. N., Yang, L., Han, Y., Qi, C., Chen, L., Luo, Y., Lin, Y.-F., Sweren, E., Chen, P., Alphonse, M. P., et al. (2026) · British Journal of Dermatology · doi:10.1093/bjd/ljag068 · Cited by 1 · see citing works

Rethinking Immune Checkpoint Inhibition in Cancer

Bakács, T., & Anderson, C. C. (2026) · Scandinavian Journal of Immunology · doi:10.1111/sji.70106 · Cited by 1 · see citing works

Long-term clinical outcomes in chronic ocular graft-versus-host disease: a retrospective cohort study

Gill, K., Burgos‐Blasco, B., Verma, A. V., Iovieno, A., & Yeung, S. N. (2026) · Eye · doi:10.1038/s41433-026-04489-y · Cited by 1 · see citing works

Anogenital lichenoid lesions: clinicopathological features and differential diagnosis

Llamas‐Velasco, M., Rozas‐Muñoz, E., & Fernández‐Figueras, M. T. (2023) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2023.10.004

Effectiveness of Oral Psoralen + UV-A (PUVA) Therapy in the Treatment of Chronic Cutaneous Graft Versus Host Disease (GVHD): A Retrospective, Observational Study Analysis from a Tertiary Care Centre

Sadhwani, M., Kulkarni, V., & Melinkeri, S. R. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-01983-3

Application of Mesenchymal Stem Cells in Graft-Versus-Host Disease as a Regenerative Therapy

Şanlı, N. M., & Timuroğlu, A. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009434

Comprehensive pharmacovigilance analysis of belumosudil: A real-world study using the FDA adverse event reporting system (FAERS)Preprint

Hua, Y.-H., Huang, X.-Y., & Wu, J. (2025) · Research Square · doi:10.21203/rs.3.rs-6215878/v1

Comparison of oral chronic graft-versus-host disease characteristics between patients with malignant and non-malignant hematopoietic disorders

Jiang, Q., Mei, G., Yong, X., Liu, Z., Zhou, Y., Wu, T., Peng, Y., Chen, X., Huang, J., Zhang, Z., et al. (2025) · BMC Oral Health · doi:10.1186/s12903-025-05785-x

Cutaneous Manifestations of Graft Versus Host Disease (GvHD)

Gniadecki, R., Taparia, M. S., Deschênes, J., Hardin, J., & Mahé, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-65292-9_17

Cutaneous ulcers in patients with chronic graft-versus-host disease: A systematic review

Nguyen, T. M., Nguyen, G. H., Tran, T. S., Kaffenberger, B. H., Cowen, E. W., & Alavi, A. (2025) · JAAD reviews. · doi:10.1016/j.jdrv.2025.03.017

Interleukin-17 and transplant immunology: clinical evidence from hematopoietic cell transplantation

Espinoza, J. L., Dac, D. T., Giang, N. H. T., & Takami, A. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2575450

‘Mucocutaneous graft-versus-host disease’

Mansilla‐Polo, M., López‐Davia, J., & Estrada, R. B. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.12.001

Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation

Yang, Z., Wang, X., Wang, X., Ding, W., Zhang, Y., Gu, Q., Wang, W., Miao, Y., Xie, P., Huang, M., et al. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03926-3

Characteristics and significance of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation at bronchoscopy

Chen, Q., Yang, Z., Ge, W., Yang, Q., Pan, W., Li, J., Lu, Y., Zeng, D., & Jiang, J. (2026) · Respiratory Research · doi:10.1186/s12931-026-03539-z

Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients

Mohammed, J. A., Couthard, C., AlGhamdi, A., Ogbeivor, C., & Hashmi, S. K. (2026) · Clinical Hematology International · doi:10.46989/001c.158500

Development and effectiveness evaluation of a mobile health-based follow-up management model for patients after hematopoietic stem cell transplantation

Zhu, X., Zhou, L., Zong, S., Li, H., Guo, S., Zhu, L., & Li, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1786747

Case report: anti-GAD65 antibody-associated epilepsy as the primary manifestation of chronic graft-versus-host disease

Yang, S., Gu, P., Tian, J. M., Tang, X., & Xue, Q. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06961-x

Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation

Luo, Y., Wu, Y., Huang, Q.-S., Yin, X.-Y., Shang, Q., Yang, Y., Zhang, A., Su, T., Su, X.-H., Liu, S., et al. (2026) · Cell Transplantation · doi:10.1177/09636897261438731

White Lesions

Jayanthi, P., & Ranganathan, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-15531-3_5

Acute and Chronic Cutaneous Graft-versus-Host Disease: Diagnosis, Treatment, and Emerging Directions

Shi, C. R., Patil, M. K., Riew, G. J., Modi, B. G., Markova, A., Cowen, E. W., & Baumrin, E. (2026) · American Journal of Clinical Dermatology · doi:10.1007/s40257-026-01010-9

Axatilimab (Niktimvo®) in chronic graft-versus-host disease: a profile of its use

Brown, M. B., & Blair, H. A. (2026) · Drugs & Therapy Perspectives · doi:10.1007/s40267-026-01230-3

Evolving Paradigms in Chronic Graft-Versus-Host Disease: From Global Immunosuppression to Precision Targeted and Cell-Based Therapies

Wang, Y., Liu, W., Huang, X., & Xiao, Y. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11131-7

Emerging strategies for the prevention and management of chronic graft-versus-host disease

Liang, X., Li, D., Ji, R., Zhang, X., Wang, X., & Zhang, X. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2664725

Advances in Cell Therapy for Chronic Graft-versus-Host Disease: Prophylactic and Therapeutic Perspectives

Taghinejad, Z., Moradi, N., Talebi, A., Jafari, L., Soleimanzadeh, H., & Hamidieh, A. A. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02120-8

New treatment approaches for fibrosing skin disorders

Moinzadeh, P., Gabrielli, A., & Krieg, T. M. (2026) · SKINdeep · doi:10.1553/skindeep.2026.189305

Real-world treatments and outcomes of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a Japanese claims analysis

Shindo, T., & Shindo, M. (2026) · International Journal of Hematology · doi:10.1007/s12185-026-04228-9

Skin Lesion Reconstruction in Graft Versus Host Disease Using Autograft From the Bone Marrow Donor Panniculectomy Tissue

King, D., Kalogeromitros, M., Gutama, B. W., Slutsky, H. L., Mubang, R. N., Wagner, A., Kitko, C. L., & Lineaweaver, W. C. (2026) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000004798

Entanglement-governed protein networks enable mechanically adaptive artificial skin for transplantation-scale skin replacementPreprint

Wang, L., Sun, Y., Liu, X., Wang, R., Huang, J., Wang, W. Y., Fan, K., Bai, J., Dong, Z., Jia, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731551

Adult Cutaneous Chronic Graft-Versus-Host Disease: An In-Depth Review

Atique, A., Kanou, M., Netchiporouk, E., Chergui, M., Popradi, G., & Litvinov, I. V. (2026) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754261455768

Belumosudil-associated neurological adverse events: evidence from FAERS and experimental validation

Zhou, Z.-H., Wang, Y.-X., Ma, J.-J., & Wu, J. (2026) · BMC Neurology · doi:10.1186/s12883-026-05032-y

The real-world safety of ruxolitinib in graft-versus-host disease treatment: a pharmacovigilance study based on the FDA adverse event reporting system

Li, Y.-Y., Xie, W.-L., Zhao, Y., Zhang, D.-Z., Mao, B., Zhou, Q., & Lai, Y.-J. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05780-1

Nefropatía membranosa con positividad tisular para PLA2R en una paciente con enfermedad injerto contra receptor crónica concomitante

Pena, A. G., Azaña-García, C., da Cunha-Naveira, M., López-Vázquez, M., & Torres-Cañete, P. (2026) · Nefrología · doi:10.1016/j.nefro.2026.501646

Nanoparticles reshaping graft-versus-host disease landscape

Maia‐Moço, L., Sarmento, B. F. C. C., & Duarte, D. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115415

Bridging Oncology and Dermatology: Integrating Dermatologic Toxicity Management Into Routine Cancer Care

Colwell, N. A. (2025) · Oncology Issues · doi:10.3928/25731777-20250401-08

Composition of immune cells in peripheral blood of patients with leukemia in remission after stem cell transplantation (HSCT) with or without graft-versus-host disease (GvHD): a comparative analysis with healthy donors

Simon, V. M., Karataş, C., Schreiner, K., Huang, A., Frischhut, A., Abdulmajid, J., Schmid, C., Frietsch, J. J., Schmeller, H., Holderried, T. A. W., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1934726

Immune signaling networks in graft-versus-host disease: From mechanism to precision therapeutic targeting

Rastegari, A., Khayatian, M., Mohebbi, F., Pakdaman, P., Azizi, A., & Khajeh, M. (2026) · Transplant Immunology · doi:10.1016/j.trim.2026.102466

Graft-versus-host disease

Hymes, S. R., Alousi, A. M., & Cowen, E. W. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.11.960 · Cited by 107 · see citing works

Chronic graft-versus-host disease – the role of dermatological treatment

Żychowska, M., Gruber, J., Tupikowska, M., & Maj, J. (2017) · Dermatology Review · doi:10.5114/dr.2017.67385

Many faces of graft‐versus‐host disease

Fernández‐Peñas, P., & Zaman, S. J. (2009) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2009.00577.x · Cited by 46 · see citing works

Cutaneous Graft-versus-Host Disease: A Guide for the Dermatologist

Häusermann, P., Walter, R. B., Halter, J. P., Biedermann, B. C., Tichelli, A., Itin, P. H., & Gratwohl, A. A. (2008) · Dermatology · doi:10.1159/000113941 · Cited by 118 · see citing works

Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern

Vasconcelos, L., Vieira, É. C., Minicucci, E. M., Sálvio, A. G., de Souza, M. P., Marques, M. E. A., & Marques, S. A. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20132128 · Cited by 2 · see citing works